MyFinsight
Home
About
Contact
emma: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, EMMA has $20,756K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
20,756
23,344
Total stockholders deficit
-59,488
-55,701
Total liabilities and stockholders' deficit
20,756
23,344
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Property and equipment,
gross
$509K
Prepaid expenses and
other current assets
$661K
Inventories, net
$1,213K
Accounts receivable, net
$2,619K
Cash and cash
equivalents
$293K
Other assets
$167K
Investment in convertible
bond
$14,876K
Right of use assets
$799K
Property and equipment,
net
$128K
Total current assets
$4,786K
Less accumulated
depreciation
$381K
Total assets
$20,756K
Accumulated deficit
-$268,116K
Accumulated other
comprehensive loss
-$481K
Net loan receivable
from ej holdings
$16,869K
Total liabilities and
stockholders' deficit
$20,756K
Total stockholders
deficit
-$59,488K
Additional paid-in capital
$225,914K
Common stock, par value
0.001 per share,...
$64K
Total liabilities
$80,244K
Notes payable, less
current portion, net of...
$2,264K
Other long-term
liabilities
$12,313K
Operating lease
liabilities, less current...
$1,498K
Total current
liabilities
$64,169K
Convertible notes payable,
net of discount
$16,804K
Notes payable,
current portion, net of...
$3,132K
Notes payable,
current portion, net of...
$7,640K
Warrant derivative
liabilities
$11K
Other current
liabilities
$14,475K
Operating lease
liabilities, current portion
$348K
Accounts payable and
accrued expenses
$21,759K
Buy me a coffee
Emmaus Life Sciences, Inc. (EMMA)
Emmaus Life Sciences, Inc. (EMMA)